Company intelligence / Profile preview

Vinalac

Jette, Brussels, Belgium

Ownership: Private
Development stage: Other

Overview

Vinalac is a Belgian pharmaceutical company specializing in the development and commercialization of nutritional supplements for women during pregnancy and breastfeeding. Its flagship product, also named Vinalac, is a comprehensive prenatal multivitamin that includes vitamins, minerals, and probiotics to support maternal and fetal health. The company focuses on high-quality formulations backed by nutritional science to address the specific physiological needs of expectant mothers. Vinalac's products are widely recommended by healthcare professionals in the Benelux region for their role in supporting the immune system and digestive health.

Therapeutic areas: Metabolic DisordersWomen's Health
Modalities: Small moleculeLive biotherapeutic product therapy
Industry: Food & Nutrition

Beyond the preview

Go deeper on Vinalac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vinalac.

Explore the full profile